Every person deserves the best when it comes to health
Discover the best solution by evaluating all the options
At Smartomica we empower patients and their physicians to choose the best course of action by presenting curated individually applicable options in an easy to digest evaluative framework. Through our partner clinics we deliver life-changing care, using our guidance to help people live longer, happier, healthier lives.
We support you at any stage of the journey
Smartomica and our partner clinics aid patients at every level of health.
We address all major types of solid and liquid tumors. Each case requires a personalized eligibility check
We want you, your family and your doctors to have the assurance that you all know about every option that could help you live better and longer. Our methods, systems, technology, experts and partners are all dedicated to bringing you the best information about what is available around the globe to help live well and achieve your goals.
Our methodology brings the vast resources of the world together to support every patient’s unique challanges.
At the age of 52 I was diagnosed with an advanced small intestine malignant tumor and had a poor reaction to surgical treatment and chemotherapy. At the time of contacting Smartomica, I was referred to palliative care in UK. The molecular study carried out by the Smartomica team identified individual target proteins in the structure of the tumor.
A personalized treatment regimen has been developed, including immunotherapy, which was the first case approved by the UK Department of Health for this kind of treatment in small intestine tumors. Currently, in stable remission without signs of disease recurrence for more than 4 years under the supervision of Smartomica medical professionals.
I will remain (hopefully for some time) forever grateful.
Yours sincerely, Kevin
After being newly diagnosed with cancer I was referred to Smartomica in 2019, looking for optimal treatment solutions. After a biopsy and a full molecular study, I was recommended to undergo local treatment by HiFu technique. I continued to receive adjuvant therapy based on repurposed drugs and reached full remission.
In 2021, during the monitoring program for Cancer Survivors in Smartomica, I was diagnosed with lung cancer. Due to the early stage at the moment of identification, I undertook pulmonary lobectomy followed by bespoke chemotherapy protocol which was based on the tumour molecular study results.